211 related articles for article (PubMed ID: 25266533)
1. Controlling strategy of dormant Mycobacterium tuberculosis.
Gan Y; Guo S
Chin Med J (Engl); 2014; 127(18):3316-21. PubMed ID: 25266533
[TBL] [Abstract][Full Text] [Related]
2. The dormant cells of Mycobacterium tuberculosis may be resuscitated by targeting-expression system of recombinant mycobacteriophage-Rpf: implication of shorter course of TB chemotherapy in the future.
Gan Y; Yao Y; Guo S
Med Hypotheses; 2015 May; 84(5):477-80. PubMed ID: 25691378
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Persistent and dormant tubercle bacilli and latent tuberculosis.
Zhang Y
Front Biosci; 2004 May; 9():1136-56. PubMed ID: 14977534
[TBL] [Abstract][Full Text] [Related]
5. New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis.
Salina EG; Ryabova O; Vocat A; Nikonenko B; Cole ST; Makarov V
J Infect Chemother; 2017 Nov; 23(11):794-797. PubMed ID: 28527650
[TBL] [Abstract][Full Text] [Related]
6. Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
Gupta VK; Kumar MM; Singh D; Bisht D; Sharma S
Infect Dis (Lond); 2018 Feb; 50(2):81-94. PubMed ID: 28933243
[TBL] [Abstract][Full Text] [Related]
7. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis: current state of knowledge: an epilogue.
Leung CC; Lange C; Zhang Y
Respirology; 2013 Oct; 18(7):1047-55. PubMed ID: 23837600
[TBL] [Abstract][Full Text] [Related]
9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment.
Kaur S; Angrish N; Gupta K; Tyagi AK; Khare G
Infect Genet Evol; 2021 Jan; 87():104662. PubMed ID: 33278633
[TBL] [Abstract][Full Text] [Related]
11. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
Chahine EB; Karaoui LR; Mansour H
Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600
[TBL] [Abstract][Full Text] [Related]
12. New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State.
Caño-Muñiz S; Anthony R; Niemann S; Alffenaar JC
Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29187395
[TBL] [Abstract][Full Text] [Related]
13. Present-day treatment of tuberculosis and latent tuberculosis infection.
Pérez-Camacho I; Rivero-Juárez A; Kindelán JM; Rivero A
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():41-6. PubMed ID: 21420566
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis: an overview.
Cruz-Knight W; Blake-Gumbs L
Prim Care; 2013 Sep; 40(3):743-56. PubMed ID: 23958367
[TBL] [Abstract][Full Text] [Related]
15. Targeting isocitrate lyase for the treatment of latent tuberculosis.
Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH
Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043
[TBL] [Abstract][Full Text] [Related]
16. Cost for tuberculosis care in developed countries: which data for an economic evaluation?
Trieste L; Turchetti G
J Rheumatol Suppl; 2014 May; 91():83-5. PubMed ID: 24789005
[TBL] [Abstract][Full Text] [Related]
17. Managing TB in the 21st century: existing and novel drug therapies.
Guy ES; Mallampalli A
Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
[TBL] [Abstract][Full Text] [Related]
18. Vaccine strategies against latent tuberculosis infection.
Andersen P
Trends Microbiol; 2007 Jan; 15(1):7-13. PubMed ID: 17141504
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis.
Ha SJ; Jeon BY; Kim SC; Kim DJ; Song MK; Sung YC; Cho SN
Gene Ther; 2003 Sep; 10(18):1592-9. PubMed ID: 12907951
[TBL] [Abstract][Full Text] [Related]
20. [Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany].
Schaberg T; Hauer B; Haas WH; Hohlfeld J; Kropp R; Loddenkemper R; Loytved G; Magdorf K; Rieder HL; Sagebiel D
Pneumologie; 2004 Apr; 58(4):255-70. PubMed ID: 15098162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
